Source: International Congress 2014 – Paediatric asthma: markers and molecules
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Tran, M. Schatz, Q. Li, D. Khatry, D. Gossage, W. Chen, R. Zeiger (Gaithersburg, San Diego, United States Of America). Elevated blood eosinophil is a risk factor for future exacerbations in asthmatic children. Eur Respir J 2014; 44: Suppl. 58, 4206

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for poor asthma control in asthmatic children Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Identifying risk factors for bronchial asthma in children Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors Year: 2014 Association of FCER2 polymorphism with IgE levels and exacerbations in asthmatic children Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014 Influence of maternal bronchial asthma clinical phenotype on development of allergies in children Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors Year: 2014 FeNO in children with asthma is related to inhaled corticosteroids adherence, not to asthma control Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014 Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab Source: International Congress 2014 – More paediatric asthma Year: 2014 Relationship between airway inflammation and bronchial responsiveness in children with and without asthma Source: International Congress 2014 – Paediatric asthma: lung function testing and more Year: 2014 Serious asthma exacerbations in a hospital setting Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Small airway indices, bronchodilator response and asthma control in children Source: International Congress 2014 – Paediatric asthma: lung function testing and more Year: 2014 Bronchodilators in school children with asthma and normal FEV1 Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Free serum IL-18 levels and responsiveness to omalizumab in patients with severe asthma Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Variability of total serum IgE in moderate-to-severe asthmatic patients Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma Source: Annual Congress 2013 –Genetic factors in airway development and disease Year: 2013 Predictors factors for asthma in patients with rhinitis Source: International Congress 2014 – Clinical allergy Year: 2014 Use of β-blockers and the risk of asthma exacerbations Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 Clinical phenotypes in asthmatic population with severe asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Investigating the role of BAFF in murine models of allergic asthma Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014 Characteristics of the adult corticosteroid-dependent severe asthma in UBIOPRED consortium Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 Allergic and non-allergic childhood asthma is characterized by novel biomarkers and signaling pathways Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014 Efficacy of omalizumab in allergic asthma by asthma severity and eosinophilic status Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015